BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11844818)

  • 1. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.
    Pearcey R; Brundage M; Drouin P; Jeffrey J; Johnston D; Lukka H; MacLean G; Souhami L; Stuart G; Tu D
    J Clin Oncol; 2002 Feb; 20(4):966-72. PubMed ID: 11844818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y
    Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
    Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
    Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
    Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Bull Cancer; 2005 Jan; 92(1):E7-12. PubMed ID: 15811845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.
    Souhami L; Seymour R; Roman TN; Stanimir GW; Trudeau M; Clark BG; Freeman CR
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):871-8. PubMed ID: 8244817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
    Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
    J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.